Clinical Trial Update: Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an oral bacterial extract to prevent wheezing-related lower respiratory tract illness; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Lower Respiratory Tract Infection

Drugs mentioned

• Oral bacterial extract (bacterial lysate)

Snippet

Sponsor: University of Arizona | Conditions: Asthma, Wheezing | Phase 2 | Status: COMPLETED